when does the patent for semaglutide expire Looming GLP-1 drug expirations draw generics firms Novo Nordisk takes legal action

It is also defined as abnormal or excessive fat accumulation that presents a health risk (1)

The formulation is commonly selected by clients seeking support with uneven-looking skin tone, dull-looking skin and long-term complexion maintenance

This includes large countries such as India, Canada, China, Brazil and Turkey which make up 40% of the worlds population and an estimated 33% of the worlds population of adults living with obesity i (see Figure 1)

A newer high-dose version called Wegovy HD, containing 7.2 mg of semaglutide, was approved for patients whose weight loss stalls on the standard 2.4 mg dose

This does not result in faster weight loss

While the vote sounds significant, it is not FDA approval